Sutro Biopharma, Inc. STRO

$8.92 -4.29% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-11-12 View →
8-K 8-K 2026-11-12 View →
4 Insider transaction 2026-09-22 View →
10-Q 10-Q 2026-08-12 View →
8-K 8-K 2026-08-12 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
4 Insider transaction 2026-06-09 View →
8-K 8-K 2026-06-08 View →
4 Insider transaction 2026-06-02 View →
10-Q 10-Q 2026-05-14 View →
8-K 8-K 2026-05-14 View →
DEF 14A DEF 14A 2026-04-22 View →
S-3 S-3 2026-03-23 View →
10-K 10-K 2026-03-23 View →
8-K 8-K 2026-03-23 View →
4 Insider transaction 2026-03-06 View →
4 Insider transaction 2026-03-06 View →
4 Insider transaction 2026-03-03 View →
4 Insider transaction 2026-03-03 View →
4 Insider transaction 2026-03-03 View →
4 Insider transaction 2026-03-03 View →
8-K 8-K 2026-02-10 View →
424B5 424B5 2026-02-10 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$8.92
Market Cap
$154.73 million
52-Week Range
$7.15 – $43.85
Average Volume
337K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.